Medical Treatment for Osteoporosis: From Molecular to Clinical Opinions
Osteoporosis is a major concern all over the world. With aging, a gradual loss of bone mass results in osteopenia and osteoporosis. Heritable factors account for 60−80% of optimal bone mineralization. Modifiable factors, such as weight-bearing exercise, nutrition, body mass, and hormonal m...
Main Authors: | Li-Ru Chen, Nai-Yu Ko, Kuo-Hu Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/20/9/2213 |
Similar Items
-
Emerging therapies for the treatment of osteoporosis
by: Garima Bhutani, et al.
Published: (2013-01-01) -
Efficacy of Denosumab Therapy Following Treatment with Bisphosphonates in Women with Osteoporosis: A Cohort Study
by: Chiara Marocco, et al.
Published: (2021-02-01) -
Bone biomarker for the clinical assessment of osteoporosis: recent developments and future perspectives
by: Tsung-Rong Kuo, et al.
Published: (2017-05-01) -
Osteoporosis: From Molecular Mechanisms to Therapies 2.0
by: Chih-Hsin Tang
Published: (2020-10-01) -
MicroRNAs in Osteoclastogenesis and Function: Potential Therapeutic Targets for Osteoporosis
by: Xiao Ji, et al.
Published: (2016-03-01)